“To date I have seen no evidence that any manufacturer of these magic potions consistently produces what they claim they produce,” writes Sasha Latypova, a former pharmaceutical R&D executive with over 25 years of experience, who says panic around “self-replicating mRNA” is not the real concern.
“The manufacturers demonstrably are unable to manufacture a single mRNA sequence to specification (e.g. coding for Wuhan “variant”), so how are they going to make a self-replicating Wuhan variant?” says Latypova.
Sasha Latypova is a former pharmaceutical R&D executive with over 25 years of experience in clinical trials, clinical technologies, and regulatory approvals. She owned and managed several contract research organizations and worked for more than 60 pharma companies worldwide. She interacted with the FDA as part of a scientific industry consortium on improving cardiac safety assessments in clinical trials. Follow her at https://x.com/sasha_latypova and read more at https://sashalatypova.substack.com
Dr. Jay Bhattacharya is a Professor of Medicine at Stanford University. He is a research associate at the National Bureau of Economics Research, a senior fellow at the Stanford Institute for Economic Policy Research, and at the Stanford Freeman Spogli Institute. His research focuses on the economics of health care around the world with a particular emphasis on the health and well-being of vulnerable populations. Follow Dr. Bhattacharya at https://x.com/drjbhattacharya